Tivic hits enrolment target for vagus nerve stimulation trial
Tivic Health has completed enrolment in a study being conducted to finetune its non-invasive vagus nerve stimulation (VNS) device that…
Neurology Devices
-
-
GE HealthCare’s SIGNA MAGNUS MRI scanner gains FDA clearance
GE HealthCare has announced the Food and Drug Administration (FDA) 510(k) clearance for its SIGNA MAGNUS magnetic resonance imaging (MRI)…
-
Sinaptica hails neuromodulation a “renaissance” in Alzheimer’s treatment
Fresh off positive data presented at the Clinical Trials on Alzheimer’s Disease 2024 (CTAD) conference earlier this month, Sinaptica’s CEO,…
-
Nihon Kohden expands neurology portfolio with Ad-Tech Medical acquisition
Nihon Kohden has expanded its portfolio of neurology electrode devices by acquiring a 71.4% stake in NeuroAdvanced Corp., the parent…
-
Zeta Surgical gains FDA 510(k) clearance for Navigation System
The US Food and Drug Administration (FDA) has granted special 510(k) clearance to the Zeta Surgical Navigation System, expanding its…
-
Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial
A Phase II clinical trial evaluating Sinaptica Therapeutics’ neuromodulation device in Alzheimer’s disease has hit its primary and key secondary…
-
Onward raises $54m to continue neuromodulation trials
Onward Medical has raised $54m (€50m) via a bookbuild offering, with proceeds going towards ongoing clinical studies and an expected…
-
Nexalin trials Halo neurostimulation device in traumatic brain injury
Nexalin Technology has partnered with the University of California, San Diego, to start a clinical trial evaluating the company’s neurostimulation…
-
Mixed results for Nexalin’s transcranial alternating current stimulation trial
Nexalin has unveiled mixed results from a clinical trial evaluating its deep intracranial frequency stimulation (DIFS) technology in patients with…
-
Natus seeks FDA clearance for new EEG device
Natus Medical has sought US Food and Drug Administration (FDA) clearance for its point-of-care EEG device. The company submitted a…
